Patents by Inventor Yong Hao

Yong Hao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11991906
    Abstract: The present disclosure provides a display substrate and a manufacturing method thereof, and a display device. The display substrate includes a plurality of pixel regions, each of the pixel regions including a display region provided with a pixel electrode and a driving region provided with a pixel circuit. The pixel circuit includes at least one pixel transistor having a first electrode and a second electrode which are coupled to an active layer of the at least one pixel transistor through connection vias, respectively. The driving region is further provided with a first plate of a storage capacitor, the first plate is insulated from and overlapped with the first electrode and the second electrode of the pixel transistor in a direction perpendicular to the display substrate, and the first plate is provided with openings at positions corresponding to at least some of the connection vias.
    Type: Grant
    Filed: July 31, 2020
    Date of Patent: May 21, 2024
    Assignees: Beijing BOE Technology Development Co., Ltd., BOE TECHNOLOGY GROUP CO., LTD.
    Inventors: Yongda Ma, Xueguang Hao, Yong Qiao, Xinyin Wu
  • Patent number: 11984070
    Abstract: The present disclosure provides a display substrate, in which power lines and compensation detection lines are alternately arranged at intervals, and two columns of pixel driving circuits extending along a second direction are arranged between any one of the power lines and one adjacent compensation detection line; and for any one of a plurality of pixel driving circuits, a power input terminal of the pixel driving circuit is electrically connected to the power line closest to the pixel driving circuit, and a compensation detection signal terminal of the pixel driving circuit is electrically connected to the compensation detection line closest to the pixel driving circuit. The present disclosure further provides a display device.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: May 14, 2024
    Assignees: BEIJING BOE TECHNOLOGY DEVELOPMENT CO., LTD., BOE TECHNOLOGY GROUP CO., LTD.
    Inventors: Chen Xu, Xueguang Hao, Yong Qiao, Xinyin Wu
  • Publication number: 20240150590
    Abstract: A coated substrate for an electronic device can include a substrate, a basecoat layer on the substrate, and an anti-fingerprint topcoat layer on the basecoat layer. The substrate can include a metal or metal alloy. The basecoat layer can include pigment particles and a first one-part thermally cured polymeric resin. The anti-fingerprint topcoat layer can include a second one-part thermally cured polymeric resin and an anti-fingerprint material. The anti-fingerprint material can include a fluoropolymer, a silane, or a combination thereof. The basecoat layer can be cured before applying the anti-fingerprint topcoat layer on the basecoat layer.
    Type: Application
    Filed: March 18, 2021
    Publication date: May 9, 2024
    Inventors: Kuan-Ting WU, Yong-Jun LI, Chi Hao CHANG, Xiao-Jun ZHU
  • Publication number: 20240141929
    Abstract: This invention discloses a pneumatic and cable-driven hybrid artificial muscle, comprising pneumatic actuator, pneumatic pressure regulating assembly, and cable drive assembly. The pneumatic pressure regulating assembly is connected to the pneumatic actuator to regulate air pressure in the pneumatic actuator for controlling the pneumatic actuator to extend or contract. The cable actuation assembly comprises a cable fixedly connected to the pneumatic actuator for controlling the pneumatic actuator to contract. In this invention, the artificial muscle employs a dual pneumatic and cable actuation mechanism. By leveraging the inherent stiffness of the pneumatic actuator, it can provide substantial actuation force for joint movement. Simultaneously, the cable actuation assembly can provide significant pulling force, effectively ensuring safety in human-machine interaction and offering sufficient bidirectional aiding force to individuals with disabilities who use the artificial muscle as an aiding actuation device.
    Type: Application
    Filed: October 4, 2023
    Publication date: May 2, 2024
    Inventors: Yong HU, Xiao Dong LI, De Hao DUAN MU, Xiao Jun WANG, Xiang CAO
  • Patent number: 11963420
    Abstract: There is provided a display substrate and a display device. The display substrate includes a first metal layer, a first insulating layer, a metal oxide layer, a second insulating layer and a second metal layer which are stacked; wherein the metal oxide layer comprises a first pattern, a second pattern and a capacitance pattern, the first metal layer comprises a first electrode plate, there is at least a first overlapping region between the first electrode plate and the capacitance pattern to form a first storage capacitor, the second metal layer comprises a second electrode plate, there is at least a second overlapping region between the second electrode plate on the base substrate and the capacitance pattern to form a second storage capacitor, and the first electrode plate and the second electrode plate have same potential.
    Type: Grant
    Filed: July 15, 2020
    Date of Patent: April 16, 2024
    Assignees: Beijing BOE Technology Development Co., Ltd., BOE Technology Group Co., Ltd.
    Inventors: Chen Xu, Xueguang Hao, Yong Qiao, Xinyin Wu
  • Publication number: 20240116986
    Abstract: The present disclosure provides a fusion peptide, a peptide-molecule conjugate containing the same, and a composition for nucleic acid delivery containing the same. The fusion peptide and the peptide-molecule conjugate containing the same of the present disclosure are expected to be used as a carrier for gene therapy intended for gene editing or treatment of diseases by delivering nucleic acids to cells or organs because it can be used for effective and safe delivery of nucleic acid materials and can be stored for a long time of 13 weeks or longer without structural destruction of the nucleic acids under harsh conditions.
    Type: Application
    Filed: March 16, 2023
    Publication date: April 11, 2024
    Applicant: Artprobio Co., Ltd.
    Inventors: Yong-Beom LIM, Youjin JUNG, Zhi Hao ZHANG
  • Publication number: 20240094419
    Abstract: A seismic quantitative prediction method for shale total organic carbon (TOC) based on sensitive parameter volumes is as follows. A target stratum for a TOC content to be measured is determined, logging curves with high correlations with TOC contents are analyzed, the logging curves are found as sensitive parameters; sample data are constructed using the sensitive parameters; a radial basis function (RBF) neural network is trained with the sample data as an input and the TOC content at a depth corresponding to the sample data as an output to obtain a RBF neural network prediction model; sensitive parameter volumes are obtained by using the sensitive parameters and post stack three-dimension seismic data to invert; prediction samples are constructed using the sensitive parameter volumes; the predicted samples are input to the RBF neural network prediction model to calculate corresponding TOC values, thereby the TOC content of the target stratum is predicted.
    Type: Application
    Filed: June 27, 2023
    Publication date: March 21, 2024
    Inventors: Chaorong Wu, Cheng Liu, Kaixing Huang, Yong Li, Yizhen Li, Junxiang Li, Yuexiang Hao
  • Publication number: 20240026061
    Abstract: A polyetherester polyol is synthesized from reactants including a) aromatic acid or aromatic anhydride or a mixture thereof, and b) OH-functional starter molecules which contain alcoholamine or amine-initiated polyether polyol. Corresponding rigid polyurethane foams produced with the polyetherester polyol are useful for insulation used in appliance applications.
    Type: Application
    Filed: December 2, 2021
    Publication date: January 25, 2024
    Applicant: BASF SE
    Inventors: Jian Feng XU, Shidhu Easwara Menon, Yong Hao Zhang, Zu Bao Nie
  • Publication number: 20210341179
    Abstract: The present disclosure provides a photovoltaic-photothermal reaction complementary full-spectrum solar utilization system, comprising: a waveband thermal reactor having a reactant flow channel and a reaction chamber therein, a photovoltaic cell attached to a surface of the waveband thermal reactor, and a full spectrum concentrator configured to concentrate full spectrum sunlight onto a surface of the photovoltaic cell, wherein the full spectrum concentrating device concentrates the full spectrum sunlight onto a upper surface of the opaque or transmissive photovoltaic cell, wherein a portion of the sunlight is converted into electric energy and another portion of the sunlight is converted into thermal energy, and wherein the thermal energy is utilized by the waveband thermal reactor to preheat reactant(s) in the reaction chamber and to make a portion of the reactant(s) to undergo an endothermic chemical reaction such that the thermal energy is stored as chemical energy.
    Type: Application
    Filed: July 14, 2021
    Publication date: November 4, 2021
    Inventors: Hongguang JIN, Hui HONG, Yong HAO, Jie SUN, Yawen ZHAO, Wenjia LI, Qibin LIU
  • Patent number: 11092359
    Abstract: The present disclosure provides a photovoltaic-photothermal reaction complementary full-spectrum solar utilization system, comprising: a waveband thermal reactor having a reactant flow channel and a reaction chamber therein, a photovoltaic cell attached to a surface of the waveband thermal reactor, and a full spectrum concentrator configured to concentrate full spectrum sunlight onto a surface of the photovoltaic cell, wherein the full spectrum concentrating device concentrates the full spectrum sunlight onto a upper surface of the opaque or transmissive photovoltaic cell, wherein a portion of the sunlight is converted into electric energy and another portion of the sunlight is converted into thermal energy, and wherein the thermal energy is utilized by the waveband thermal reactor to preheat reactant(s) in the reaction chamber and to make a portion of the reactant(s) to undergo an endothermic chemical reaction such that the thermal energy is stored as chemical energy.
    Type: Grant
    Filed: February 6, 2016
    Date of Patent: August 17, 2021
    Assignee: Institute of Engineering Thermophysics, Chinese Academy of Sciences
    Inventors: Hongguang Jin, Hui Hong, Yong Hao, Jie Sun, Yawen Zhao, Wenjia Li, Qibin Liu
  • Publication number: 20200352976
    Abstract: Disclosed herein is a method for treating cancer with DNA-hypomethylating agents. Also disclosed herein is a method of selecting a treatment for a subject. Treatment can be given to a subject for more than one cycle of treatment to obtain improved efficacy of the treatment.
    Type: Application
    Filed: May 5, 2020
    Publication date: November 12, 2020
    Inventors: Mohammad AZAB, Yong HAO, Harold KEER
  • Publication number: 20200323685
    Abstract: A method of decreasing intraocular pressure (IOP) in an eye of a patient in need thereof includes implanting a first lacrimal implant through a firsts punctum and into a first lacrimal canaliculus of the eye of the patient. The method may further comprise implanting a second lacrimal implant through a second punctum and into a second lacrimal canaliculus of the eye of the patient, and releasing, on a sustained basis a therapeutically effective amount of an intraocular pressure-reducing therapeutic agent.
    Type: Application
    Filed: April 27, 2020
    Publication date: October 15, 2020
    Applicant: Mati Therapeutics, Inc.
    Inventors: Suzanne Cadden, Yong Hao, Deepank Utkhede, Valery Rubinchik, Charles Richard Kjelbotn
  • Patent number: 10632012
    Abstract: A method of decreasing intraocular pressure (IOP) in an eye of a patient in need thereof includes implanting a first lacrimal implant through a firsts punctum and into a first lacrimal canaliculus of the eye of the patient. The method may further comprise implanting a second lacrimal implant through a second punctum and into a second lacrimal canaliculus of the eye of the patient, and releasing, on a sustained basis a therapeutically effective amount of an intraocular pressure-reducing therapeutic agent.
    Type: Grant
    Filed: April 3, 2017
    Date of Patent: April 28, 2020
    Assignee: Mati Therapeutics Inc.
    Inventors: Suzanne Cadden, Yong Hao, Deepank Utkhede, Valery Rubinchik, Charles Richard Kjelbotn
  • Patent number: 10463158
    Abstract: A wall-mounted foldable chair has: a supporting frame, a rotatable frame, and a seating member. The supporting frame is provided with the two assembling bars fixed on a wall surface, the other end of the supporting frame is connected with an axial tube. The two assembling bars are parallel to each other, the shaft tube is provided with a shaft rod, and the shaft rod is rotatably pivoted to the connecting rod. The rotatable frame is provided with a rotation shaft and at least two supporting leg member parallel to the rotation shaft, the two supporting leg member is capable of standing on the ground, and a connecting bar is horizontally disposed between the two supporting leg members for pivoting at the other end of the connecting rod. The seating member is provided with a pad member and the two secure bars.
    Type: Grant
    Filed: February 7, 2018
    Date of Patent: November 5, 2019
    Assignee: YO YUH INST. CO., LTD.
    Inventor: Yong-Hao Lin
  • Publication number: 20190239651
    Abstract: A wall-mounted foldable chair has: a supporting frame, a rotatable frame, and a seating member. The supporting frame is provided with the two assembling bars fixed on a wall surface, the other end of the supporting frame is connected with an axial tube. The two assembling bars are parallel to each other, the shaft tube is provided with a shaft rod, and the shaft rod is rotatably pivoted to the connecting rod. The rotatable frame is provided with a rotation shaft and at least two supporting leg member parallel to the rotation shaft, the two supporting leg member is capable of standing on the ground, and a connecting bar is horizontally disposed between the two supporting leg members for pivoting at the other end of the connecting rod. The seating member is provided with a pad member and the two secure bars.
    Type: Application
    Filed: February 7, 2018
    Publication date: August 8, 2019
    Inventor: Yong-Hao LIN
  • Publication number: 20190091066
    Abstract: A method of decreasing intraocular pressure (IOP) in an eye of a patient in need thereof includes implanting a first lacrimal implant through an upper punctum and into an upper lacrimal canaliculus of the eye of the patient. The method may further comprise implanting a second lacrimal implant through a lower punctum and into a lower lacrimal canaliculus of the eye of the patient, and releasing, on a sustained basis a therapeutically effective amount of an intraocular pressure-reducing therapeutic agent.
    Type: Application
    Filed: May 22, 2018
    Publication date: March 28, 2019
    Applicant: Mati Therapeutics Inc.
    Inventors: Suzanne Cadden, Yong Hao, Deepank Utkhede
  • Patent number: 9974685
    Abstract: A method of decreasing intraocular pressure (IOP) in an eye of a patient in need thereof includes implanting a first lacrimal implant through an upper punctum and into an upper lacrimal canaliculus of the eye of the patient. The method may further comprise implanting a second lacrimal implant through a lower punctum and into a lower lacrimal canaliculus of the eye of the patient, and releasing, on a sustained basis a therapeutically effective amount of an intraocular pressure-reducing therapeutic agent.
    Type: Grant
    Filed: February 27, 2013
    Date of Patent: May 22, 2018
    Assignee: Mati Therapeutics
    Inventors: Suzanne Cadden, Yong Hao, Deepank Utkhede
  • Publication number: 20180041158
    Abstract: The present disclosure provides a photovoltaic-photothermal reaction complementary full-spectrum solar utilization system, comprising: a waveband thermal reactor having a reactant flow channel and a reaction chamber therein, a photovoltaic cell attached to a surface of the waveband thermal reactor, and a full spectrum concentrator configured to concentrate full spectrum sunlight onto a surface of the photovoltaic cell, wherein the full spectrum concentrating device concentrates the full spectrum sunlight onto a upper surface of the opaque or transmissive photovoltaic cell, wherein a portion of the sunlight is converted into electric energy and another portion of the sunlight is converted into thermal energy, and wherein the thermal energy is utilized by the waveband thermal reactor to preheat reactant(s) in the reaction chamber and to make a portion of the reactant(s) to undergo an endothermic chemical reaction such that the thermal energy is stored as chemical energy.
    Type: Application
    Filed: February 6, 2016
    Publication date: February 8, 2018
    Inventors: Hongguang JIN, Hui HONG, Yong HAO, Jie SUN, Yawen ZHAO, Wenjia LI
  • Publication number: 20170202853
    Abstract: A method of decreasing intraocular pressure (IOP) in an eye of a patient in need thereof includes implanting a first lacrimal implant through a firsts punctum and into a first lacrimal canaliculus of the eye of the patient. The method may further comprise implanting a second lacrimal implant through a second punctum and into a second lacrimal canaliculus of the eye of the patient, and releasing, on a sustained basis a therapeutically effective amount of an intraocular pressure-reducing therapeutic agent.
    Type: Application
    Filed: April 3, 2017
    Publication date: July 20, 2017
    Applicant: Mati Therapeutics Inc.
    Inventors: Suzanne Cadden, Yong Hao, Deepank Utkhede, Valery Rubinchik, Charles Richard Kjelbotn
  • Patent number: 9610271
    Abstract: A method of decreasing intraocular pressure (IOP) in an eye of a patient in need thereof includes implanting a first lacrimal implant through a firsts punctum and into a first lacrimal canaliculus of the eye of the patient. The method may further comprise implanting a second lacrimal implant through a second punctum and into a second lacrimal canaliculus of the eye of the patient, and releasing, on a sustained basis a therapeutically effective amount of an intraocular pressure-reducing therapeutic agent.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: April 4, 2017
    Assignee: Mati Therapeutics Inc.
    Inventors: Suzanne Cadden, Yong Hao, Deepank Utkhede, Valery Rubinchik, Charles Richard Kjellbotn